Overview
SIST EN ISO 10993-11:2018 (ISO 10993-11:2017) - "Biological evaluation of medical devices - Part 11: Tests for systemic toxicity" - specifies requirements and provides guidance on procedures to evaluate the potential of medical device materials to cause adverse systemic reactions. Endorsed as a European standard (EN ISO 10993-11:2018), it supports conformity assessment for EU medical device directives and is part of the ISO 10993 biocompatibility series.
Key topics and technical requirements
- Scope: Focuses on systemic toxicity assessment of device materials and extracts rather than mechanical or functional performance of devices.
- Guidance on test selection and study design: Helps determine when systemic toxicity testing is needed and how to plan appropriate biological studies based on exposure, duration and clinical use.
- Integration with risk management: Aligned with ISO 10993-1 and referencing risk-management expectations (e.g., ISO 14971) to ensure testing is proportionate to identified risks.
- Combined studies: Describes when systemic toxicity studies can be combined with local effect evaluations (for example, in conjunction with ISO 10993-6) and when implantation studies may satisfy systemic requirements.
- Regulatory relevance: Includes informative annexes (ZA/ZB) mapping the standard to EU Directives (93/42/EEC and 90/385/EEC), supporting presumption of conformity when normative clauses are followed.
Note: This summary highlights the standard’s intent and relationships; consult the full text for detailed procedural requirements and test-method specifics.
Practical applications - who uses this standard
- Medical device manufacturers preparing biocompatibility evidence for new or modified devices.
- Regulatory affairs professionals compiling technical files and demonstrating conformity with EU directives.
- Biocompatibility scientists and toxicologists designing systemic toxicity studies and interpreting results.
- Contract testing laboratories executing extract testing and in vivo/in vitro studies as specified.
- Notified bodies and auditors assessing compliance during conformity assessment and certification reviews.
Why it matters (value)
- Ensures a consistent, risk-based approach to identify systemic hazards from device materials.
- Helps manufacturers generate defensible data for safety dossiers and regulatory submissions.
- Facilitates harmonized assessment across jurisdictions through alignment with the ISO 10993 series and EN adoption.
Related standards
- ISO 10993-1 - Biological evaluation framework and general principles (normative reference).
- ISO 10993-6 - Tests for local effects after implantation (relevant for combined studies).
- EN ISO 14971 / ISO 14971 - Medical device risk management (referenced for risk-reduction expectations).
- Other parts of the ISO 10993 series covering specific endpoints (irritation, sensitization, genotoxicity, etc.).
Keywords: ISO 10993-11, EN ISO 10993-11:2018, systemic toxicity, medical device biocompatibility, toxicity testing, biological evaluation, risk management.